This month, we talk with David Narrow, chief operating officer of Baltimore startup Sonavex, which is developing a patent-pending, ultrasound-based system that pinpoints potential postsurgical blood clots.
Narrow started developing EchoSure, Sonavex’s ultrasound system, with Devin O’Brien Coon in 2012, when they were both in their first semester of Johns Hopkins’ biomedical engineering graduate program at the Center for Bioengineering Innovation and Design.